FindMyKOL

William Kelly, DO

Enriched profile

Chair & Professor, Department of Medical Oncology · Thomas Jefferson University

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Philadelphia, PA · Northeast · United StatesSpecialtyMedical OncologyFocusProstate Cancer+4
Active KOLFindMyKOL type: NationalLatest publicationNone indexedOnline presenceNone verifiedPayments2021–2025NIH funding2017–2026Why? →

William Kelly is Chair & Professor, Department of Medical Oncology at Thomas Jefferson University. ClinicalTrials.gov lists 11 registered studies with this person as an investigator.

Data verified 26 Oct 2026

Overview

Updated 28 Oct 2026

William Kevin Kelly, DO, is Chair & Professor, Department of Medical Oncology at Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 10 companies, 3 NIH-funded awards (2017–2026).

  • Top research focus: Prostate Cancer
  • 11 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 10 companies

Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Prostate Cancer7 trialsNeuro-Oncology / Glioma2 trialsLeukemia (AML/ALL/CML/CLL)1 trialLymphoma1 trialMultiple Myeloma1 trialThromboembolism1 trialEmbolism1 trialSpasm1 trialBronchial Spasm1 trial

Research focus

OpenAlex concept fingerprint
Prostate CancerNeuro-Oncology / GliomaLeukemia (AML/ALL/CML/CLL)LymphomaMultiple Myeloma

Drugs & molecules

across trials, industry payments and publications
Nubeqageneric · DarolutamideClinical trials—Industry payments9Publications—Xofigogeneric · RadiumClinical trials—Industry payments9Publications—Cabometyxgeneric · CabozantinibClinical trials—Industry payments4Publications—Erleadageneric · ApalutamideClinical trials—Industry payments3Publications—Lunsumiogeneric · MosunetuzumabClinical trials—Industry payments2Publications—Polivygeneric · Polatuzumab vedotinClinical trials—Industry payments2Publications—Tecentriqgeneric · AtezolizumabClinical trials—Industry payments2Publications—Venclextageneric · VenetoclaxClinical trials—Industry payments2Publications—Orgovyxgeneric · RelugolixClinical trials—Industry payments1Publications—Pluvictogeneric · Vipivotide tetraxetanClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments9Exelixis Inc.Clinical trials—Industry payments4Memorial Sloan Kettering Cancer CenterClinical trials4Industry payments—Amgen Inc.Clinical trials—Industry payments3Janssen Scientific Affairs, LLCClinical trials—Industry payments3Novartis Pharmaceuticals CorporationClinical trials—Industry payments3Genentech, Inc.Clinical trials—Industry payments2Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityClinical trials2Industry payments—The University of Texas Health Science Center at San AntonioClinical trials2Industry payments—Alliance for Clinical Trials in OncologyClinical trials1Industry payments—Genentech USA, Inc.Clinical trials—Industry payments1Janssen Research & Development, LLCClinical trials—Industry payments1Myovant Sciences Inc.Clinical trials—Industry payments1National Cancer Institute (NCI)Clinical trials1Industry payments—Tempus AI, IncClinical trials—Industry payments1University of New MexicoClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
0h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials ↓
10companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2017–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 28 Oct 2026

Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:

All 11 trial records: search, sort and filter.Explore →

Industry payments

Updated 28 Oct 2026

10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 16 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    81.3%
    Androgen Receptor Inhibitor31.4%
    Xtandi100%
    Part D≥14 patients
    Gonadotropin Releasing Hormone Receptor Antagonist16.3%
    Orgovyx100%
    Part D≥12 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    11.9%
    Corticosteroid11.9%
    Prednisone100%
    Part D<11 patients

  • Sensory organs

    3.8%
    Corticosteroid3.8%
    Dexamethasone100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)77.1% facility · 22.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 28 Oct 2026

3 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:

All 94 award records: search, sort and filter.Explore →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Background & recognition

Updated 28 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • American Board of Internal Medicine/Medical Oncology

    1993 and 2003

    2003
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
  • American Board of Internal Medicine
    1991
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
  • DO

    Philadelphia College of Osteopathic Medicine

    1986
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
  • DO
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗

Editorial & leadership roles

journal and society appointments
  • Medical oncology co-chair

    NCI Genitourinary Cancers Steering Committee

    2018
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
  • Editorial board

    Clinical Prostate Cancer

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗
  • Editorial board

    Journal of Clinical Oncology

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.